Opinion
Drew Moghanaki
Drew Moghanaki/LinkedIn

Drew Moghanaki: SBRT for stage I NSCLC – When Guidelines and Experience Diverge

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:

“I learned today that the language in the NCCN guidelines defining who should get SBRT for stage I NSCLC is not broadly appreciated by pulmonologists who feel more than qualified to determine when a patient is high surgical risk.”

SBRT

More posts featuring Drew Moghanaki.

cancer Drew Moghanaki NCCN guidelines NSCLC OncoDaily Oncology SBRT